The
Pfizer’s pill to treat the disease caused by the coronavirus showed extraordinary results in a clinical trial, reducing hospitalization and death by 89% among high-risk Covid-19 patients. The company said Tuesday it
The administration has also ordered about 3.1 million courses of a pill from
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.